cryptostats .stream
$DYN Overview

Dynamic

Dynamic sentiment is down with 4852 interactions.

Sentiment by last 24 hours:
0% 100%
Sentiment score is 33 out of 100, and it's based on the number of positive, negative and neutral mentions of $DYN on social media.

Highlights about Dynamic on social media

4852 unique individuals are talking about Dynamic and it is in most mentions and activity from collected posts. In the last 24 hours, across all social media platforms, Dynamic has an sentiment score of 33 out of 100.

On Twitter, people are mostly bearish about Dynamic. Trend were down about Dynamic. These sentiments are based on 865 tweets.

On Reddit, Dynamic was mentioned in 0 Reddit posts and there were 0 interactions about Dynamic. On average, there were more upvotes compared to downvotes on Reddit posts and more upvotes compared to downvotes on Reddit comments.

Related topics: $lly, $wrb, $ffiv, $pltr, $rna, $pcvx, morgan stanley, $ions, $arwr, $vir, asos, $bpmc, $shls, $rxrx, $clsk, stocks, $lnth, $swtx, $janx, discord

Social media posts

Open Outcrier
@OpenOutcrier

$DYN (-31.1% pre) Dyne Therapeutics Announces New Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating Unprecedented Dystrophin Expression and Functional Improvement in Multiple Cohorts - STockTitan

notreload
@thudderwicks

$DYN -31% [Dyne Therapeutics said new clinical data from its ongoing Phase 1/2 DELIVER trial of DYNE-251, in patients with DMD, showed no related serious TEAE other than in two participants at the 40mg/kg dose with events potentially related to study drug]

Jon Najarian
@jonnajarian

$DYN Dyne Therapeutics announces C-level executive changes & clinical data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy

DickMedChem
@DickMedChem

$DYN One of the most hyped biotechs since the beginning the year - stock nearly quadrupled... Wondering what's going on in the company with three C-people stepping down at the same time with the clinical data release...

Hottest Stocks Now
@HottestStockNow

Dyne Therapeutics Reveals New Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Showing Unprecedented Dystrophin Expression and Functional Improvement in Multiple Cohorts $DYN, #DyneTherapeutics, #Dyne_tx, #DyneTx

Hottest Stocks Now
@HottestStockNow

Dyne Therapeutics Building Team to Prepare for Commercialization as Company Pursues Expedited Approval Pathways for DM1 and DMD Clinical Programs $DYN, #DyneTherapeutics, #Dyne_tx, #DyneTx

Monaco
@monaco_biotech

$DYN Dyne Therapeutics Announces New Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne M... - DYN • BioPharmCatalyst

Dyne Therapeutics
@Dyne_tx

Congratulations to our recently promoted #Dynamos! Thank you for your dedication & commitment to people living with serious muscle diseases.

Dyne Therapeutics
@Dyne_tx

Today is #NationalAccessibleAirTravelDay, which was founded by @Allwheelsup. Learn about their commitment to making airplanes wheelchair accessible for patients who rely on mobility aids and need safe seating:

Trade Alerts, Trade Ideas and Crypto 🇺🇸
@AlertTrade

DOWNSIDE MOMO: $DYN Dyne Therapeutics, Inc. via ➡️

Dyne Therapeutics
@Dyne_tx

World #Duchenne Awareness Day is September 7. This year’s theme is “Raise Your Voice for Duchenne.” Learn more about the day and how to get involved: #WDAD2024 #DMD

Dyne Therapeutics
@Dyne_tx

Our #Dynamos gathered for our 3rd FORCE for Good Service Day, dedicating the day to supporting local nonprofits in the #Boston area. Thanks to our partners at @LS_Cares for helping us support the community! @TheFoodProject @c2cboston @CommunityServ @MspcaAngell @MysticMyRWA

Dyne Therapeutics
@Dyne_tx

Bright, motivated, driven, and energetic are just a few of the characteristics of a #Dynamo. Listen to our team describe the unique attributes of employees and visit our website to learn more about working at Dyne:

Stock Market Genius
@stockmktgenius

Hot Market Alert: Dyne Therapeutics ($DYN) stock is soaring! Riding high in a trending industry. #Stocks #Investing Heating Up: Dyne Therapeutics Symbol: $DYN Price: 31.08 Volume: 1,359,149 % Up: 434%

BiotechMag
@MagBiotech

Dyne Therapeutics announces CEO transition. It is time for $DYN to advance pipeline and leverage the FORCE™ platform in other diseases. 👇🏻 🧵

Dyne Therapeutics
@Dyne_tx

We honored #RareDiseaseDay at our annual event, bringing together community members, #Dynamos & their families. Our theme was “All Access,” where #DMD, #DM1 & #FSHD community experts led education booths to provide information & insights to our Dynamos. Read their reflections:

Susan Matesanz
@suzmatMD

Great news - this is promising, excited to see what protein expression looks like at the higher doses. Higher protein levels with less frequent dosing would be great for patients! #duchenne #dmd Dyne Therapeutics Announces Positive Initial Clinical Data

Nick Rokke
@NickRokke

Constructive action in biotech stocks today. $XBI is bouncing strongly off a retest of the annual AVWAP. And the 50-day MA is about to start sloping upwards. We're seeing buying in $AMGN, $CRNX, $DYN, and $MRNA as well. Also love to see the action in genetic editing stocks like $EDIT, $CRSP...

Eugenio Gallegos Deveze
@eugeniodeveze

$DYN después del gap bajista recupera el soporte

Michel Beazley
@BeazleyMichel

@TaPlot I took a huge hit from the biotech $DYN today....still dont know which part of my strategy goes wrong....

avidresearch
@avidresearch

@Mark748779211 Looks like a tough sell, at least for DMD. DM1 is likely where some value lies. DM1 has become hyper competitive. $DYN.

Brian
@ekafanyRS

$DYN head over to $CAPR the only really successful therapeutic for DMD and

Jonathan Faison
@jfais20

$ARWR (NP) Michael on efforts in muscle $DYN $RNA

Sonic the Hedgefund
@sonichedgefund

$ARWR $DYN from Discord. Btw, @ArrowheadPharma KOL webinar on Muscle platform is in two days.

gusichan
@gusichan

20/05 Breakouts: $VFS $MARA $PTCT $DYN $SOUN $EWTX $STOK $BKKT $FTEL

gusichan
@gusichan

Portfolio: $CRBP (1,5%) $INOD (1%) $RNA (1,5%) $HRTX (1%) $HIMS (2,5%) $DYN (2,5%) $POWL (8,5%) Exposure = 18% Open Risk = -0,22% Focuslist: $ARQT

Steven Spencer
@sspencer_smb

today's #1 In Play $DYN with full reversal from opening flush below S3 now at R2. has traded over 5X its ADV already.

ACCESSWIRE News
@AccesswireNews

$DYN Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dyne Therapeutics, Inc.(DYN) and Encourages ...

SharksTracker
@sharks_tracker

Insider transaction alert: Kersten Dirk sells over $5.8M worth of Dyne Therapeutics shares. #DYN #insidertracking $DYN

SharksTracker
@sharks_tracker

Insider transaction alert: Kersten Dirk sells $7.0M worth of Dyne Therapeutics shares, reducing ownership by 155706 shares. #DYN #insidertracking $DYN

SharksTracker
@sharks_tracker

Insider transaction alert: Kersten Dirk sells over $7.9M worth of Dyne Therapeutics shares. #DYN #insidertracking $DYN

SharksTracker
@sharks_tracker

Insider transaction alert: Kersten Dirk sells nearly $8.1M worth of Dyne Therapeutics shares at $45.79 each, reducing ownership to 630,964 shares. #DYN #insidertracking $DYN

SharksTracker
@sharks_tracker

Insider transaction alert: Kersten Dirk sold over $8.7M worth of Dyne Therapeutics shares, reducing ownership to 805,549 shares. #DYN #insidertracking $DYN

stock scope
@MarcJacksonLA

- $DYN - Stifel Sees Pullback in Dyne Therapeutics Shares As A Buying Opportunity -

stock scope
@MarcJacksonLA

$DYN - Dyne Therapeutics Announces New Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating Unprecedented Dystrophin Expression and Functional Improvement in Multiple Cohorts

stock scope
@MarcJacksonLA

- $DYN - Dyne Therapeutics Announces Key Leadership Appointment -

stock scope
@MarcJacksonLA

$DYN - Dyne Touts ‘Unprecedented’ Dystrophin Expression in Phase I/II DMD Trial for Exon-Skipping Therapy -

Riley Rosebee
@be_rosebee

Trends with No Friends, 5-20-2024 New 52-Week Highs led New Lows — 240 vs. 25. Dyne Therapeutics $DYN is the best of the best. Atlas Energy Solutions $AESI and Blue Bird $BLBD are notable new highs. Li Auto $LI is the worst of the worst. Click the link to view today's 52W highs and lows...

Dyne Therapeutics
@Dyne_tx

In honor of #WorldDuchenneAwarenessDay, Dyne hosted Marissa Penrod, CEO of @TeamJosephInfo, to discuss the important work the organization is doing to elevate voices we seldom hear—caregivers of people living with Duchenne—and the challenges they encounter. #WDAD2024

Dirk Haussecker
@RNAiAnalyst

$DYN not just 1, but 2 officers not only sold at the top when the moment M&A rumor broke, the form 144 statement was filed the same day. You'd think they knew the rumor was about to break...and selling can only mean 1 thing: not a credible rumor.

zohm
@zohmbastic

$DYN

Even
@TTRAmyloid

The market is sensitive about adverse events with the $rna and $dyn tfr platform because of a case of bilateral thalamic stroke in $rna marina study that resulted in a clinical hold which has been lifted. The case was deemed not associated with the drug by the fda. Bilateral thalamic strokes are very...

Michel Doepke
@doepke_michel

@adar170 BTW: $DYN valuation turns to dust today - was insane too. 😉

Jack Hall
@Hall8Jack

@avidresearch Imo $rna and $dyn value mostly in Myotonic (DM1) indication. Even then safety for chronic dosing will be a concern. Very large drug conjugates…. $srpt

rabmanduky
@rabmanduky

@CloisterRes Alot of gamblers in $dyn who keep believing the takeover theory. They're going to spin it as good news, hold on. It's going to drip down , as the reason why entire c suite left, first goes through insiders

WhiteBIT
@WhiteBit

🔈AMA with DYN is coming soon!🔈 Join us on November 5th (2:00 p.m. UTC) on YouTube for the AMA with Clayton Saliba (Co-founder and CEO at @dualityofficial): The prize pool is 1000 $DYN. ➡️Submit your questions via this form:

Dyne Therapeutics
@Dyne_tx

Today we announced new clinical data from our DELIVER trial in #DMD demonstrating unprecedented dystrophin expression and functional improvement in multiple cohorts. Join our live webcast at 8:00 a.m. ET. Learn more: #biotech #data #clinicaltrials

Stock Market News
@Stock_Market_Pr

#BronsteinGewirtzGrossmanLLCClassAction (DYN) INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Dyne Therapeutics, Inc. and Encourages Investors to Contact the Firm!: NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) --…

SharksTracker
@sharks_tracker

Insider alert: Kersten Dirk sells over $5M worth of Dyne Therapeutics shares, reducing ownership by 26,408 shares. #DYN #insidertracking $DYN

MAISA
@MaisaCorp

Dyne Therapeutics $DYN announced new clinical data from its ongoing Phase 1/2 DELIVER trial of DYNE-251 in patients with Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping.

Michel Beazley
@BeazleyMichel

@NickDrendel @Deepvue my biotech $DYN gapped down over 30% 2 days ago. it hurt so much

Allison Gatlin
@IBD_AGatlin

$DYN crashed after several key executives, including the CMO, announced their departures in a news release following its update for an Exondys 51 rival. Exondys is $SRPT's treatment for DMD patients amenable to exon 51 skipping.

BiopharmIQ by Amp
@BiopharmIQ

$DYN -33% 🔴 New Data: Ph1/2 DELIVER » DYNE-251 #DMD » higher dystrophin expression 🆚 previous PMO Tx » improvements in multiple endpoints » update on path to registration YE2024 Interested in companies working in Rare disease? 🙋‍♂️ See our free report👇

Moshe Finkelstein
@MichaelFinkels1

$DYN This is why Biotechs are so risky especially when they don’t have the C and A in CAN SLIM.

avidresearch
@avidresearch

So is $DYN DMD program worth anything? mktcap ~$3.12B 👀

Francesca Gianna Arcolin
@francescaarcol4

@dyakon_official @MToktomushova $DYN

Azuki 3593 - Midori ⛩️
@Kristen_Colwell

#Blockchain may resolve many of the weaknesses that lead to healthcare data breaches, but how will this new technology find its way to all corners of the #healthcare industry? #infosec #patientsafety #cybersecurity $DYN

The Business Journals
@bizjournals

This week there is new Duchenne data from Dyne Therapeutics, additional funding going to Somite Therapeutics and a new Bristol Myers Squibb leader headed to Foghorn Therapeutics.

Dyne Therapeutics
@Dyne_tx

This Saturday is #WorldDuchenneAwarenessDay! We’re looking forward to joining the @JettFoundation for their #WDAD24 events to raise awareness of #DMD and honor the community. Register to learn about their luncheon and virtual panel: #JettFoundationWDAD

Trade Alerts, Trade Ideas and Crypto 🇺🇸
@AlertTrade

🔎 Trending Stocks : $DYN Dyne Therapeutics Inc #TrendingStocks September 03, 2024 04:48:57 pm

Hector Gavilán
@gaviln4_hector

@MMemepump @DigiFinex $DYN #Dyakon 🔥

CARMELO SELIS
@SelisCarmelo

@coingecko @dyakon_official #DYAKON #DYN $DYN

The Business Journals
@bizjournals

This week there is new Duchenne data from Dyne Therapeutics, additional funding going to Somite Therapeutics and a new Bristol Myers Squibb leader headed to Foghorn Therapeutics.

Boston Business Journal
@BosBizJournal

This week there is new Duchenne data from Dyne Therapeutics, additional funding going to Somite Therapeutics and a new Bristol Myers Squibb leader headed to Foghorn Therapeutics.

snicobio
@snicobio

Past 5 years we've seen the emergence and value creation of muscle delivery with $RNA $DYN. Optimistic that the next 5 will be in CNS delivery. $LLY $DNLI $VYGR

Sports_Bios
@Sports_bios

Was thinking about this particular exchg in the $BIIB 2Q call a lot - .. other than some of the more obvious (good fit but can be expensive) names [e.g $RNA $DYN] - what are the others with this list of characteristics - 1) low volume, high value, genetics? 2) Rare disease/Immuno, reasonably derisked...

PopPopTrades
@PopPopTrades

One and done in #AwesomeCallsTrading today . $DYN was a short if it broke 25.50. Took it short at 28.50 amd covered at 24. Almost 2x daily goal. Done before 10AM. Thanks @AjTrader7 You are the 🐐!

Duality
@dualityofficial

Dynamic withdrawals from the Duality Platform are now available for verified KYC customers! $SEQ $DYN

McGriddle Connoisseur
@CloisterRes

Wonder if $RNA is a long against $DYN short. Class effects in safety or just $DYN?

BowTiedBiotech 🧪🔬🧬
@BowTiedBiotech

He is right - no need to look at the data $DYN 👇

mets17
@adar170

lol We won the football game if you take out the 2 touchdowns scored in the 4th

Francesca Gianna Arcolin
@francescaarcol4

@Oli62069902 @MToktomushova @Ralvero @dyakon_official $DYN

Francesca Gianna Arcolin
@francescaarcol4

@gaviln4_hector @MToktomushova @AltCryptoWhale @dyakon_official $DYN

Hector Gavilán
@gaviln4_hector

@miroslav_grgic @cryptoworld202 @dyakon_official $DYN #Dyakon 🔥

watermelon101
@jianguangchen

Yesterday's $DYN news is disappointing . They might not have a therapeutic window. exited $DYN long time ago as $RNA is more advanced. Decided to add more $RNA here at around $40. Still expensive and risky (as SAE might show up later ) but feel its the only game in town now.

Joe Kunkle
@OptionsHawk

$DYN - Third straight day 1,000 September $35 calls were bought

Dyne Therapeutics
@Dyne_tx

The 2024 Muscle to Keep Life Moving™ fundraising event was spectacular! Thank you to the @FSHDSociety for partnering with us and to everyone who participated to help raise $145,000 to provide care and support for those with serious muscle diseases. #raredisease

2iQ
@2iqresearch

On Sep 4, Pres./CEO @Dyne_tx, John G. Cox, bought 32,000 shares, valued at $1.061M. A day prior, Dyne Therapeutics reported new clinical data from its ongoing DYNE-251 trials; anticipated to treat Duchenne muscular dystrophy (DMD). $DYN is up by a whopping 185.90% in a year.

Market Rebellion
@marketrebellion

6⃣0⃣ Seconds $PCVX $SHLS $SOC $DYN $RXRX $CLSK Rebel's Edge 1pm EST

avidresearch
@avidresearch

Who is buying $DYN 👀?

About Dynamic

Dynamic (DYN) is the native asset of the Dynamic blockchain hosted and developed by Duality Blockchain Solutions LLC. The blockchain and its proprietary infrastructure was launched in 2014 with the aim of solving critical data and identity management issues in the healthcare sector.

Information:
  • Name: Dynamic
  • Symbol: DYN
  • Started At: 3/26/2017
Explorer:
Community:
Tags:
  • Mineable
  • PoW
  • Argon2
  • Masternodes